期刊文献+

中药清毒栓对HeLa细胞MHC-Ⅰ抗原呈递通路相关分子表达的影响 被引量:2

Influence of Qingdu suppository on the expression of MHC-Ⅰ antigen presentation pathway associated molecules in HeLa cell
原文传递
导出
摘要 目的:探讨中药清毒栓治疗宫颈高危型人乳头瘤病毒(HPV)感染的分子机制。方法:以HPV18阳性的宫颈癌细胞系He La为细胞模型,清毒栓水提醇沉液、β-榄香烯、干扰素α-2b进行干预;分别采用Western blot及Real-time PCR检测主要组织相容性复合物-Ⅰ(MHC-Ⅰ)抗原呈递通路相关分子TAP1、TAP2、LMP2、LMP7的蛋白及基因表达差异。结果:与对照组相比,清毒栓及β-榄香烯均可显著上调He La细胞内抗原呈递通路相关分子TAP1、TAP2、LMP2、LMP7的蛋白表达(P<0.05),清毒栓可上调4种分子的基因表达(P<0.05),β-榄香烯仅能可上调TAP2的基因表达(P<0.05),干扰素α-2b对该4种分子的基因表达无影响。结论:中药清毒栓可通过调节抗原呈递通路相关分子的蛋白及基因表达,起到促进抗原呈递的作用,这可能是该方疗效的作用机制之一。 Objective: To explore the molecular mechanism of Qingdu suppository (QDS) in the treatment of high risk HPV infection. Methods: Human cervical cancer cell line HeLa as the model (HPV 18 positive) was cultured in vitro and treated by the extraction of QDS, β-elemene and IFN-α-2b. The protein and gene expression of MHC- I antigen presentation pathway associated molecules including TAP1, TAP2, LMP2 and LMP7 were detected by Western blot and Real-time PCR. Results: Compared with the control group, the treatment drugs could increase the protein expression of antigen presentation pathway associated molecules TAP1, TAP2, LMP2 and LMP7 in cell line HeLa (P〈0.05). QDS could up-regulate the mRNA expression of four molecules (P〈0.05), β -elemene could only up-regulate the gene expression of TAP2 (P〈0.05), while there was no significant difference after treatment with IFN-α -2b. Conclusion: QDS could promote antigen presentation through up-regulating the gene and protein expression of antigen presentation associated molecules. This might be one of the mechanisms of QDS effects. β -elemene and IFN α -2b should affect post transcriptional events to promote protein expression of antigen presentation associated molecules, ultimately promoted antigen presentation of infected cells.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2014年第12期3926-3929,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.30873278) 河北联合大学博士科研启动项目(No.35755599)~~
关键词 清毒栓 Β-榄香烯 干扰素Α-2B 抗原呈递 抗原处理相关性转运体 潜伏膜蛋白 Qingdu suppository β -elemene IFN- α -2b Antigen presentation TAP LMP
  • 相关文献

参考文献12

  • 1Ahmedin Jemal,Freddie Bray,Melissa M Center,et al.Global cancer statistics.CA Cancer J Clin,2011,61(2):69-90.
  • 2Shreya Kanodia,Laura M.Fahey,W.Martin Kast.Mechanisms used by human papillonmviruses to escape the host immune response. Curt Cancer Drug Targets,2007,7(1):79-89.
  • 3Chen C M,Shyu M P,Au L C,et al.Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach.J Med Virol, 1994,44(2):206-211.
  • 4金哲,曹颖,于妍妍,楼姣英,张冬梅.清毒栓及β-榄香烯对宫颈癌HeLa细胞HLA-Ⅰ类抗原表达的影响[J].北京中医药大学学报,2012,35(8):529-534. 被引量:3
  • 5Marfade Lourdes Mora-Garcfal,Alfonso Duenas-Gonzalez,Jorge Hernandez-Montes,et al.Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer ceils by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid.J Transl Med,2006,4:55.
  • 6Kenneth J Livak,Thomas D Schmittgen.Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△CT method.Methods,2001,25(4):402-408.
  • 7张明星,李桂玲.中草药抗人宫颈癌作用机制研究概况[J].中华中医药杂志,2013,28(3):761-764. 被引量:5
  • 8Frazer I H.Prevention of cervical cancer through papillomavirus vaccination.Nat Rev Immunol,2004A(1):46-54.
  • 9Pudney J,Quayle A J,Anderson D J.Immunological microenviromnents in the human vagina and cervix:mediators of cellular immunity are concentrated in the cervical transformation zone.Biol Reprod,2005,73(6): 1253-1263.
  • 10Eric W Hewitt.The MHC class I antigen presentation pathway:strategise for viral immune evasion.Immunology, 2003,110(2):163-169.

二级参考文献40

  • 1王传社,李燕燕,陈娜,李寅增,肖军军,孟书聪,董晓敏,果德安,黄启福.脂蟾毒配基对人宫颈癌Hela裸鼠移植瘤生长的抑制作用[J].北京中医药大学学报,2006,29(3):184-187. 被引量:12
  • 2武燕.宫颈癌患者Th1/Th2细胞因子表达水平的研究[J].肿瘤研究与临床,2006,18(5):310-312. 被引量:24
  • 3周永芹,韩莉.蜈蚣提取物对宫颈癌Caski细胞增殖的抑制效应[J].中国组织工程研究与临床康复,2007,11(34):6805-6807. 被引量:25
  • 4AHMEDIN JEMAL, FREDDIE BRAY, MELISSA M CENTER, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011, 61 (2) : 69 -90.
  • 5WALBOOMERS JM, JACOBS MV, MANOS MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999, 189 ( 1 ) :12 - 19.
  • 6SAEWHA JEON, B LYNN .AlLEN-HOFFMANN, PAUL F LAMBERT. Integration of Human Papillomavirus Type 16 into the Human Genome Correlates with a Selective Growth Advantage of Cells[J]. J Virol, 1995, 69(5) : 2989 -2997.
  • 7NIKOLAOS T GEORGOPOULOS, JOANNE L PROFFITT,G ERIC BLAIR. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16, and 18 E7 oncoproteins [ J ]. Oncogene, 2000, 19(42) : 4930 -4935.
  • 8MARIA DE LOURDES MG, ALFONSO DG, JORGE HM, et al. Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid [ J ]. J Transl Med, 2006, 4:55.
  • 9KENNETH J LIVAK, THOMAS D SCHMITTGEN. Analysis of relative gene expression data using real-time quantitative PCR and the 2-A ACT method[J]. Methods, 2001, 25(4) :402-408.
  • 10SHREYA KANODIA, LAURA M FAHEY, W MARTIN KAST. Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response [ J ]. Curr Cancer Drug Tar, 2007, 7 ( 1 ) : 79 - 89.

共引文献6

同被引文献22

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部